Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,984 | -5,873 | -2,990 | -15,380 | -12,236 |
| Depreciation Amortization | 169 | 116 | 58 | 240 | 182 |
| Accounts payable and accrued liabilities | -1,324 | -1,290 | -1,068 | 1,282 | 1,419 |
| Other Working Capital | -1,753 | -1,434 | -2,137 | 855 | 1,436 |
| Other Operating Activity | 1,856 | 1,495 | 1,177 | -870 | -1,069 |
| Operating Cash Flow | $-9,036 | $-6,986 | $-4,960 | $-13,873 | $-10,268 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-4 | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Financing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Beginning Cash Position | 15,045 | 15,045 | 15,045 | 28,918 | 28,918 |
| End Cash Position | 6,005 | 8,059 | 10,085 | 15,045 | 18,650 |
| Net Cash Flow | $-9,040 | $-6,986 | $-4,960 | $-13,873 | $-10,268 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,036 | -6,986 | -4,960 | -13,873 | -10,268 |
| Capital Expenditure | -4 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -9,040 | -6,986 | -4,960 | -13,873 | -10,268 |